TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
172 hedge funds and large institutions have $444M invested in Tvardi Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 49 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
172
Holders Change
+5
Holders Change %
+2.99%
% of All Funds
3%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
41
Increased
53
Reduced
49
Closed
36
Calls
$5.8M
Puts
$5.45M
Net Calls
+$358K
Net Calls Change
-$31.9M
Top Buyers
| 1 |
BlackRock
New York
|
+$51.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.94M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$9.53M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.02M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.1M |
Top Sellers
| 1 |
First Manhattan
New York
|
-$47.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$17.9M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
-$15.8M |
| 4 |
RCP
Rho Capital Partners
New York
|
-$15M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$7.54M |
